Posterior Blepharoconjunctivitis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Posterior Blepharoconjunctivitis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

TerminatedPhase 2

NCT01220258

A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1% (P08641)

One objective of this study is to determine the levels of markers of inflammation on the eyelid margin of subjects with blepharoconjunctivitis and compare them…

United States29 participantsStarted 2010-11

Treatment: Azithromycin ophthalmic solution, 1%